Waleria Healthtech has announced clinical trial results for its branded Shatavari root extract, aspurūs, reporting improvements in sexual function and several measures of wellbeing among reproductive-age women who are experiencing low sexual desire.
Published in the Journal of Medicine and Life, the randomised, double-blind, placebo-controlled trial involved 70 women aged 18-45 years in India.
Participants received either 300 mg of Shatavari extract daily or a placebo for an eight-week period.
The primary outcome was change in the Female Sexual Function Index (FSFI), a validated questionnaire assessing aspects of sexual function.
By Day 56, the total FSFI score had increased by 67.96% in the Shatavari group, compared with 7.58% in the placebo group — a statistically significant difference.
Researchers also reported improvements in sexual encounter outcomes, sleep disturbance and fatigue.
Fatigue Severity Scale scores improved by 60.05% in the intervention group, compared with 4.45% in the placebo group, while sleep disturbance scores improved by 21.83%.
The extract was also well tolerated by the participants.
The study focused on women in their reproductive years rather than combining younger participants with peri- and postmenopausal populations.
Waleria founder Komal Baldwa said the research aimed to examine sexual wellbeing alongside factors such as fatigue, sleep and physical comfort.
Shatavari ingredient profile
Aspurūs is a full-spectrum extract of Asparagus racemosus, commonly known as Shatavari, a botanical traditionally used in Ayurvedic medicine.
According to Waleria, its extraction process is designed to preserve the root’s broader phytochemical profile, including seven identified bioactives, with the ingredient standardised to five per cent Shatavarins.
The company is seeking to develop the ingredient for women's health applications across different life stages, with its clinical research portfolio also including investigations into Shatavari supplementation for menopausal symptoms.
These latest clinical trial findings add to research into botanical ingredients for women’s sexual health and wellbeing.
However, it's important to note that the trial was relatively small and conducted at a single centre, meaning larger studies will be needed to confirm the findings and establish how consistently the effects can be replicated.
